Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.KYTHERA files NDA for ATX-101 to reduce unwanted submental fat
The NDA submission is based on positive and consistent results from two pivotal Phase III trials – REFINE-1 and REFINE-2. In these trials, which were reported in late
The NDA submission is based on positive and consistent results from two pivotal Phase III trials – REFINE-1 and REFINE-2. In these trials, which were reported in late
The company said it will work closely work with the FDA in accelerating its development program for CVac to potentially bring this treatment option to patients in the
University of Northern Colorado professor of Chemistry and Biochemistry and member of the Scientific Advisory Board at Medical Marijuana Sciences, a wholly owned subsidiary of Nuvilex, Richard Hyslop
Located adjacent to CSL Behring’s manufacturing plant for plasma products, the new facility is the centerpiece of the company’s $250m expansion at its Broadmeadows site and will play
The company has introduced 0.25mg, 0.5mg, 1mg, 2mg, 3mg and 4mg doses of the Risperidone Tablets, which are used to treat schizophrenia and bipolar disorder. According to IMS
According to the company, in both the trials ‘bivalent rLP2086’ was observed to generate bactericidal responses, a measurement of functional immune response, against diverse meningococcal serogroup B test
Psoriasis is a non-contagious chronic disease in which the immune system causes skin cells to grow at a faster rate. The company said that the trial met all
The drug is a combination of umeclidinium(UMEC), a long-acting muscarinic antagonist (LAMA) that helps lung function, and vilanterol (VI), a long-acting beta2 agonist (LABA), in a single inhaler,
The investigational regimen includes the fixed-dose combination of ABT-450/ritonavir (150/100mg) co-formulated with ombitasvir (ABT-267) 25mg, dosed once daily, and dasabuvir (ABT-333) 250mg with or without ribavirin (weight-based), dosed
AuriPro is a proprietary, sustained-exposure formulation of the antibiotic ciprofloxacin that has been designed for administration by ear, nose and throat (ENT) specialists for the treatment of a